[Disorders of hemostasis].
D000293:Adolescent; D000347:Afibrinogenemia / Q000175:diagnosis; D000925:Anticoagulants / Q000009:adverse effects; D001777:Blood Coagulation; D001778:Blood Coagulation Disorders / Q000139:chemically induced / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D006467:Hemophilia A / Q000175:diagnosis / Q000188:drug therapy; D006474:Hemorrhagic Disorders / Q000209:etiology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D012769:Shock / Q000209:etiology
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D006493:Heparin
Störungen der Blutstillung.